APT Medical (SHA:688617) attributable profit rose 6.8% year over year to 198.1 million yuan in the third quarter, according to a Saturday filing with the Shanghai bourse.
Shares plunged 13% during the close of trading on Monday.
The electrophysiology and vascular interventional medical device manufacturer logged earnings per share of 1.40 yuan, up 6.9% from the year-ago period.
Operating income grew 25% year on year to 653.6 million yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.